BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
1-Year Return
36.91%
This Quarter Return
+11.66%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$490M
AUM Growth
+$62.9M
(+15%)
Cap. Flow
+$18.8M
Cap. Flow
% of AUM
3.84%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Lineage Cell Therapeutics
LCTX
|
+$15.1M |
| 2 |
STAAR Surgical
STAA
|
+$4.83M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$1.09M |
Sector Composition
| 1 | Healthcare | 60.08% |
| 2 | Consumer Staples | 35.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Monster Beverage
MNST
$63.2B
| $173M | 35.35% |
9,594,816
| – | – |
|
|
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $160M | 32.73% |
1,619,968
-11,000
| -0.7% | -$1.09M |
|
|
3
STAAR Surgical
STAA
$1.37B
| $67.6M | 13.79% |
7,417,582
+530,487
| +8% | +$4.83M |
|
|
4
Lineage Cell Therapeutics
LCTX
$306M
| $66.5M | 13.57% |
22,095,035
+5,006,257
| +29% | +$15.1M |
|
|
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
| $22.4M | 4.57% |
817,029
| – | – |
|